Drugs / Liquid nitrogen
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT07810101 | Sep 2026 → Feb 2027 expected | gingival disorder | Al-Azhar University | Enrolling by invitation | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02572557 | Dec 2016 → Dec 2021 | obstructive lung disease | University Medical Center Groningen | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01084824 Comparator | Jun 2007 → Jun 2008 | common wart | North Idaho Dermatology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liquid nitrogen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02572557 ↗ |
| Modality | Other / unclassified | “Spray cryotherapy (SCT) using liquid nitrogen” NCT02572557 ↗ |
| Route | Topical | “Topical application of liquid nitrogen” NCT07810101 ↗ |